Trial Compares VR and Dual-Task Training for Balance in Parkinson's Disease
A clinical trial is evaluating the efficacy of cognitive-based balance rehabilitation using Virtual Reality versus traditional Dual-Task Training in Parkinson's Disease patients.
Phase III
Parkinson's Disease therapies
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This trial represents a pivotal exploration of innovative non-pharmacological interventions for Parkinson's Disease, potentially reshaping treatment approaches in neurorehabilitation. The outcomes could influence competitive dynamics in the market for rehabilitation technologies, making it essential for pharma strategy teams to stay informed.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor the trial's primary and secondary outcome results, particularly the efficacy of VR in improving balance and cognitive functions.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.